BRSYF
Price
$3.15
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
PDEX
Price
$28.05
Change
-$0.30 (-1.06%)
Updated
Oct 17 closing price
20 days until earnings call
Ad is loading...

BRSYF vs PDEX

Header iconBRSYF vs PDEX Comparison
Open Charts BRSYF vs PDEXBanner chart's image
Brainsway
Price$3.15
Change-$0.00 (-0.00%)
Volume$500
CapitalizationN/A
Pro-Dex
Price$28.05
Change-$0.30 (-1.06%)
Volume$9.79K
CapitalizationN/A
View a ticker or compare two or three
BRSYF vs PDEX Comparison Chart
Loading...
PDEX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BRSYF vs. PDEX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRSYF is a Hold and PDEX is a StrongSell.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (BRSYF: $3.15 vs. PDEX: $28.05)
Brand notoriety: BRSYF and PDEX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BRSYF: 47% vs. PDEX: 45%
Market capitalization -- BRSYF: $39.9M vs. PDEX: $61.8M
BRSYF [@Medical Specialties] is valued at $39.9M. PDEX’s [@Medical Specialties] market capitalization is $61.8M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRSYF’s FA Score shows that 1 FA rating(s) are green whilePDEX’s FA Score has 1 green FA rating(s).

  • BRSYF’s FA Score: 1 green, 4 red.
  • PDEX’s FA Score: 1 green, 4 red.
According to our system of comparison, PDEX is a better buy in the long-term than BRSYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDEX’s TA Score shows that 3 TA indicator(s) are bullish.

  • PDEX’s TA Score: 3 bullish, 5 bearish.

Price Growth

BRSYF (@Medical Specialties) experienced а 0.00% price change this week, while PDEX (@Medical Specialties) price change was -3.74% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

PDEX is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PDEX($61.8M) has a higher market cap than BRSYF($39.9M). BRSYF YTD gains are higher at: 65.789 vs. PDEX (60.103). PDEX has higher annual earnings (EBITDA): 5.58M vs. BRSYF (-13.7M). BRSYF has more cash in the bank: 44.3M vs. PDEX (7.09M). BRSYF has less debt than PDEX: BRSYF (754K) vs PDEX (13.5M). PDEX has higher revenues than BRSYF: PDEX (48.2M) vs BRSYF (25.8M).
BRSYFPDEXBRSYF / PDEX
Capitalization39.9M61.8M65%
EBITDA-13.7M5.58M-245%
Gain YTD65.78960.103109%
P/E RatioN/A20.89-
Revenue25.8M48.2M54%
Total Cash44.3M7.09M625%
Total Debt754K13.5M6%
FUNDAMENTALS RATINGS
BRSYF vs PDEX: Fundamental Ratings
BRSYF
PDEX
OUTLOOK RATING
1..100
4373
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
10058
SMR RATING
1..100
8879
PRICE GROWTH RATING
1..100
3638
P/E GROWTH RATING
1..100
275
SEASONALITY SCORE
1..100
22n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDEX's Valuation (70) in the Medical Or Nursing Services industry is in the same range as BRSYF (88) in the null industry. This means that PDEX’s stock grew similarly to BRSYF’s over the last 12 months.

PDEX's Profit vs Risk Rating (58) in the Medical Or Nursing Services industry is somewhat better than the same rating for BRSYF (100) in the null industry. This means that PDEX’s stock grew somewhat faster than BRSYF’s over the last 12 months.

PDEX's SMR Rating (79) in the Medical Or Nursing Services industry is in the same range as BRSYF (88) in the null industry. This means that PDEX’s stock grew similarly to BRSYF’s over the last 12 months.

BRSYF's Price Growth Rating (36) in the null industry is in the same range as PDEX (38) in the Medical Or Nursing Services industry. This means that BRSYF’s stock grew similarly to PDEX’s over the last 12 months.

PDEX's P/E Growth Rating (5) in the Medical Or Nursing Services industry is in the same range as BRSYF (27) in the null industry. This means that PDEX’s stock grew similarly to BRSYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PDEX
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
69%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
PDEX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

BRSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRSYF has been loosely correlated with ANSLY. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BRSYF jumps, then ANSLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRSYF
1D Price
Change %
BRSYF100%
N/A
ANSLY - BRSYF
55%
Loosely correlated
N/A
IOBCF - BRSYF
32%
Poorly correlated
+8.39%
WUXIF - BRSYF
27%
Poorly correlated
N/A
SNWV - BRSYF
25%
Poorly correlated
-14.15%
PDEX - BRSYF
23%
Poorly correlated
-1.06%
More

PDEX and

Correlation & Price change

A.I.dvisor tells us that PDEX and LDXHF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDEX and LDXHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
-1.06%
LDXHF - PDEX
25%
Poorly correlated
N/A
PRE - PDEX
23%
Poorly correlated
-2.16%
BDX - PDEX
23%
Poorly correlated
+0.04%
BRSYF - PDEX
23%
Poorly correlated
N/A
GKOS - PDEX
23%
Poorly correlated
+0.82%
More